Lisinopril/HCTZ 20mg/12 — Class II drug recall D-1030-2020
Terminated recall by RemedyRepack Inc., reported 2020-03-25, distributed in PA. Presence of Foreign Tablets/Capsules: This is a spin-off recall of D-1581-2019 due to a product complaint wher
| Recall number | D-1030-2020 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | RemedyRepack Inc., Indiana, PA, United States |
| Recall initiated | 2019-08-05 |
| Classified | 2020-03-16 |
| Reported by FDA | 2020-03-25 |
| Terminated | 2023-06-02 |
| Distributed | PA |
| Quantity | 480 tablets |
| NDC | 68180-0519-02, 70518-0382-03 |
| Lot numbers | J0322819-091418 |
| Expiration dates | 2019-09-30 |
Product
Lisinopril/HCTZ 20mg/12.5mg Tablet, QTY: 30 tablets per blister card, MFG: Lupin Pharma Baltimore, MD 21202, NDC 68180-0519-02 (Original NDC of 500 count bottle); 70518-0382-03 (Repackaged NDC for blister cards).
Reason for recall
Presence of Foreign Tablets/Capsules: This is a spin-off recall of D-1581-2019 due to a product complaint where one of Lupin's Fenofibrate 145mg was observed in the 500 s count product bottle.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1030-2020. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.